Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Xenetic Biosciences Cash Position $14.9M

Xenetic Biosciences Cash Position $14.9M

Xenetic Biosciences (NASDAQ:XBIO) will report on Q2 2022.

byBill Haddad

August 12, 2022

1 minute read

Xenetic Biosciences (NASDAQ:XBIO) will report on Q2 2022.

Now That Tech Is Amid AI Frenzy, SoftBank Mulls Purchase of Remaining Stake in Chip Designer Arm

By Anusuya Lahiri

August 14, 8:39 AM

SoftBank Group Corp (OTC: SFTBF) (OTC: SFTBY) is weighing the acquisition of the remaining 25% stake in

AMZN

Western Digital Set To Merge With Japan’s Kioxia, Further Consolidating Chip Market

By Anusuya Lahiri

October 13, 12:53 PM

Japanese chipmaker Kioxia Holdings and its U.S.

SSNLF

Bitcoin Could Drop To These Two Levels If It Falls Below $63,300, Warns Technical Analyst

By Khyathi Dalal

April 25, 10:52 AM

Bitcoin (CRYPTO: BTC) currently trading at around $63,440 with a drop of 4.1% in the past 24 hours, prompting technical analyst Ali Mart

BTC

Datasea Q2 EPS $(0.05) Up From $(0.07) YoY, Sales $425.71K Down From $8.98M YoY

By Happy Mohamed

February 13, 5:34 PM

Datasea (NASDAQ:DTSS) reported quarterly losses of $(0.05) per share. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported $425.71 thousand in sales this

DTSS

Xenetic Biosciences Cash Position $14.9M

Related Posts

Now That Tech Is Amid AI Frenzy, SoftBank Mulls Purchase of Remaining Stake in Chip Designer Arm

Western Digital Set To Merge With Japan’s Kioxia, Further Consolidating Chip Market

Bitcoin Could Drop To These Two Levels If It Falls Below $63,300, Warns Technical Analyst

Datasea Q2 EPS $(0.05) Up From $(0.07) YoY, Sales $425.71K Down From $8.98M YoY